Your Messages Inbox (38) 
Your Unread Messages
See All
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid
Journal of Bone and Mineral Metabolism, 11/06/09
Polyzos SA et al. – These data suggest that serum HCY levels are increased in patients with PDB. A single ZOL infusion results in a decrease in HCY levels that might represent another mechanism for the reduction of the activity of PDB achieved by ZOL.
Stergios A. Polyzos, 11/06/09
| This is the first report of serum homocysteine (HCY), folate and vitamin B12 in patients with Paget's disease of bone (PDB). There are limited data regarding the effect of bisphosphonates on HCY, folate or vitamin B12. In this study, higher serum HCY and folate levels were observed in the pagetic compared with the control group and HCY levels were decreased 3 months after zoledronic acid (ZOL) infusion and remained essentially unchanged up to the end of the study. Since the increased HCY could lead to increased activation and formation of osteoclasts, this effect of ZOL on HCY might represent another mechanism for the reduction of the activity of PDB achieved by ZOL. |
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Sponsor
Article Search
Sponsor